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In multicellular organisms, specialized functions are
delegated to distinct cell types whose identity and
functional integrity are maintained upon challenge.
However, little is known about the mechanisms
enabling lineage inheritance and their biological im-
plications. Regulatory T (Treg) cells, which express
the transcription factor Foxp3, suppress fatal auto-
immunity throughout the lifespan of animals. Here,
we show that a dedicated Foxp3 intronic element
CNS2 maintains Treg cell lineage identity by acting
as a sensor of the essential Treg cell growth factor
IL-2 and its downstream target STAT5. CNS2 sus-
tains Foxp3 expression during division of mature
Treg cells when IL-2 is limiting and counteracts
proinflammatory cytokine signaling that leads to the
loss of Foxp3. CNS2-mediated stable inheritance of
Foxp3 expression is critical for adequate suppres-
sion of diverse types of chronic inflammation by
Treg cells and prevents their differentiation into in-
flammatory effector cells. The described mechanism
may represent a general principle of the inheritance
of differentiated cell states.INTRODUCTION
Differentiated somatic cells exhibit distinct functions and behav-
iors that are specified by their developmental programs. In the
past two decades, tremendous progress has been achieved in
elucidating genetic and epigenetic mechanisms underlying dif-
ferentiation of specialized cell lineages and organ development.
However, little is known about how, and to what degree, the
differentiated cells maintain their fate or lose their identity in
response to changing environment or upon cell division, the
two conditions that may disturb the inheritance of lineage-spec-
ifying factors (Sa´nchez Alvarado and Yamanaka, 2014). Conse-
quently, factors that affect identity and function of a given cell
type andmolecular basis of their robustness upon environmentalperturbations and its biological significance remain poorly
understood.
The adaptive immune systemwith its somatic diversification of
antigen receptors of essentially unlimited specificity affords ver-
tebrates with an effective means of defense against previously
encountered and new infectious agents. Potentially deleterious
self-reactivity and ‘‘collateral’’ damage resulting in an impair-
ment or loss of tissue function has been a tradeoff for the
emergence of adaptive immunity. Central to limiting excessive
immune responses and associated inflammation is their sup-
pression mediated by regulatory T (Treg) cells, a subset of
CD4+ T cells expressing X-chromosome-encoded transcription
factor Foxp3. Foxp3 is specifically expressed in Treg cells and
plays a key role in their differentiation and function (Josefowicz
et al., 2012). During the differentiation of Treg cells, Foxp3 is
induced in response to TCR and IL-2 signaling (Josefowicz
et al., 2012; Sekiya et al., 2013), and Foxp3 protein expression
is required for Treg cell function (Gavin et al., 2007; Lin et al.,
2007). In addition to conferring cellular identity and functional
competence during differentiation of Treg cells, Foxp3 plays an
essential role in their maintenance because deletion of a condi-
tional Foxp3 allele in differentiated Treg cells results in a loss of
their function (Williams and Rudensky, 2007). Genetic fate map-
ping using inducible and constitutive Cre revealed heritable and
stable Foxp3 expression in the Treg cell population in unchal-
lenged mice as well as in the context of infection and autoim-
mune inflammation (Miyao et al., 2012; Rubtsov et al., 2010). In
contrast, almost half of newly generated extrathymic Treg cells
lose Foxp3 expression (Josefowicz et al., 2012). Thus, Treg cells
represent a distinct cell lineage and Foxp3 is its late acting
specification factor whose stable expression is a requisite for
preserving Treg cell identity and functional integrity.
These findings also implied the existence of a distinct mecha-
nism that ensures Treg cell lineage stability. A conserved intronic
regulatory element CNS2 is required for the maintenance of
Foxp3 expression in the progeny of dividing Treg cells but
does not affect Foxp3 induction and its amount on a per cell ba-
sis (Zheng et al., 2010). CNS2 can be bound by numerous tran-
scription factors, including STAT5, STAT3, and Foxp3, but how
these factors regulate Foxp3 expression during cell division re-
mains unknown (Samstein et al., 2012; Xu et al., 2010; Yao
et al., 2007; Zheng et al., 2010).Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc. 749
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Figure 1. CNS2 Opposes Cell-Cycle-Dependent Loss of Foxp3 Expression in Mature Treg Cells
(A) Loss of Foxp3 expression during cell division. Highly purified Foxp3gfp Treg cells were labeled with CellTrace Violet and were activated by CD3 and CD28
antibody-coated beads in the presence of 200 U/ml IL-2 for 5 days. The data represent one of three independent experiments.
(legend continued on next page)
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CNS2 contains a stretch of CpG bases that are fully methyl-
ated in precursor cells but undergo demethylation upon Foxp3
expression (Floess et al., 2007; Kim and Leonard, 2007; Polan-
sky et al., 2008; Toker et al., 2013). Previous studies suggested
a correlation between the methylated state of CNS2 and unsta-
ble Foxp3 expression (Bailey-Bucktrout et al., 2013; Floess et al.,
2007; Polansky et al., 2008). Genetic targeting of the pivotal DNA
methyltransferase Dnmt1 or pharmacological inhibition of DNA
methyltransferase activity results in a sharp increase in Foxp3
induction efficiency upon activation of naive T cells (Floess
et al., 2007; Josefowicz et al., 2009; Kim and Leonard, 2007).
Despite a considerable body of work, the biological role of
CNS2 in the regulation of Foxp3 expression has not been eluci-
dated, and a mechanistic understanding of CNS2 function and
its biological role are lacking. Here, we demonstrated that
CNS2 serves as a sensor of IL-2/STAT5 signaling that prevents
Treg conversion into effector T cells upon exposure to proinflam-
matory cytokines. CNS2 conferred stable inheritance of Foxp3
expression at limiting amounts of IL-2, which was of particular
significance for control of chronic inflammation in a wide range
of biological contexts.
RESULTS
Heritability of Foxp3 Expression and CpGMethylation in
the Foxp3 Locus
Lymphopenic or proinflammatory conditions are associated
with the instability of Treg cells; however, its cause and conse-
quences have not been examined (Bailey-Bucktrout et al.,
2013; Komatsu et al., 2013). We observed accumulation of
Foxp3 cells (exTreg) upon Treg cell division in response to
TCR stimulation in vitro. This was unlikely due to the contam-
ination with effector T cells because the starting population
contained 99.8% Foxp3+ cells (Figure 1A and data not shown).
To demonstrate that the loss of Foxp3 was due to division
of Treg cells, we blocked cell-cycle progression using phar-
macological inhibitors targeting different stages of the cell cy-
cle. The cell-cycle blockade fully rescued Foxp3 expression(B) Blockage of cell division prevents loss of Foxp3 expression. Flow cytometric
comparison to control nondividing and dividing Treg cells. The data represent on
(C) CpGmethylation (mCpG) levels in the Foxp3 locus during Treg cell division in v
in biological replicate samples were averaged at each site of the Foxp3 locus from
cells (n = 3), nondividing (n = 3) and dividing (n = 3) Treg cells, and in vitro exTreg
Mean ± SEM; t test comparisons of mCpG in nondividing and dividing Treg cells
(D) CNS2 sustains heritable Foxp3 expression in dividing mature Treg cells. Highl
the presence of CD3 and CD28 antibody-coated beads and 500 U/ml IL-2 for 4
Gating on CellTrace intensity is similar to (A). Mean ± SEM.
(E) Similar gene expression profiles of CNS2-deficient and -sufficient resting
CD44lowCD62Lhigh rTreg cells from male Foxp3gfp and Foxp3DCNS2-gfp littermat
sufficient and -deficient rTreg cells were compared to those up- and downregula
and wild-type rTreg cells (n = 3 each). The numbers of genes in each compariso
(F) Acute deletion ofCNS2 in mature Treg cells was induced upon tamoxifen treatm
cell transfer. Treg (GFP+) cells were sorted by FACS and were transferred togeth
(Tcrb/ Tcrd/). At 7 weeks after transfer, Foxp3 expression was analyzed and th
with newly isolated naive CD4+Foxp3 T cells into secondary Tcrb/ Tcrd/ re
(G) Flow cytometric analysis of Foxp3 expression before cell transfer and after
tamoxifen-treated Foxp3CNS2fl-gfp UBCCre-ERT2 R26Y and Foxp3CNS2fl-gfp R26Y
experiments.
See also Figure S1.(Figure 1B), suggesting that its loss was indeed cell-cycle
dependent.
To investigate whether CpGmethylation (mCpG) plays a role in
the regulation of heritable Foxp3 expression, we examined the
mCpG levels across the Foxp3 locus by bisulfite sequencing in
resting and dividing Treg cells as compared to non-Treg cells
that do not express Foxp3 or ‘‘exTreg’’ cells that have lost
Foxp3 expression either in vitro or in vivo. In agreement with pre-
vious reports, 1.5 kb, CNS2, and exon 1 were methylated in
non-Treg cells and were largely or fully demethylated in Treg
cells (Floess et al., 2007; Ohkura et al., 2012) but were remethy-
lated in ‘‘exTreg’’ cells that have lost Foxp3 expression either
in vivo or in vitro. Importantly, we found a statistically significant
increase in mCpG at sites including the 1.5 kb region, CNS2,
and exon-1 in dividing Foxp3+ Treg cells (Figure 1C and Figures
S1A–S1C available online). Accordingly, low dose of a DNA
methyltransferase inhibitor 5-aza-deoxycytidine (5-aza-dC) pre-
vented loss of Foxp3 expression in Treg cells that underwent a
comparable number of cell divisions in the presence or absence
of the drug (Figure S1D). These findings suggest that CpG
methylation might be actively regulated when Treg cells divide
and may affect the heritability of Foxp3 expression.
CNS2 Opposes Cell-Cycle-Dependent Loss of Foxp3
Expression in Mature Treg Cells
Studies of Foxp3DCNS2-gfp mice on a mixed genetic background
showed that CNS2 maintains Foxp3 expression in Treg cells
(Zheng et al., 2010). To explore the biological role of CNS2 and
the molecular mechanisms of its function in depth, we back-
crossed Foxp3DCNS2-gfp mice onto a C57BL/6 (B6) background
(n > 10) and bred them to CNS2-sufficient Foxp3gfp B6 mice ex-
pressing the exact same Foxp3 reporter allele, which serves as
an ideal control when segregated into male littermates (Bettini
et al., 2012; Darce et al., 2012). In agreement with previous
results on a mixed genetic background (Zheng et al., 2010),
significantly more Treg cells isolated from Foxp3DCNS2-gfp B6
mice with the germline CNS2 deficiency lost Foxp3 expression
upon division in comparison to CNS2-sufficient Foxp3gfp B6analysis of Foxp3 expression in Treg cells treated with indicated inhibitors in
e of three independent experiments.
itro and after loss of Foxp3 expression (exTreg) in vitro and in vivo. mCpG levels
>5,000 reads in naive CD4+Foxp3 T cells (n = 2), ex vivo isolated natural Treg
(n = 4) and in vivo exTreg (n = 2) cells. Red dots represent individual CpG sites.
are shown (see also Figures S1A–S1C).
y purified Treg cells from Foxp3gfp and Foxp3DCNS2-gfp mice were cocultured in
–5 days. The data represent one of more than four independent experiments.
Treg cells (rTreg). Poly(A) RNA libraries were generated using FACS-sorted
es. Relative gene expression levels (cumulative fraction of genes) in CNS2-
ted in GFP+ cells (‘‘Treg wannabes’’) from Foxp3gfpko/WT heterozygous females
n group are indicated in parentheses.
ent of Foxp3CNS2fl-gfpUBCCre-ERT2 R26Ymale mice 7 days before the adoptive
er with allelically marked naive CD4+Foxp3 T cells into T-cell-deficient hosts
e remaining Foxp3+ (GFP+) Treg cells were purified by FACS and cotransferred
cipients. Foxp3 expression was assessed 5 weeks later.
recovery. Transferred YFP+ and YFP Treg cells were originally isolated from
mice, respectively. The data represent one of more than three independent
Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc. 751
littermates (Figure 1D). To exclude a possibility that CNS2 may
have a direct impact on the expression of genes other than
Foxp3 through long-range chromatin interactions that could
contribute to impaired Foxp3 maintenance, we performed
RNA-seq gene expression analysis of CNS2-sufficient and -defi-
cient resting Treg cells. Comparable gene expression observed
in these CNS2-sufficient and -deficient Treg cell populations
(Figure 1E) indicated that CNS2 has a direct and specific role
in the maintenance of Foxp3 expression and Treg cell fate in
dividing activated Treg cells.
These findings raised the question of at which stage of Treg
cell differentiation CNS2 exerts its function. To address this, we
deleted a conditionalCNS2fl allele inmature Treg cells. Treg cells
expressing Foxp3gfp reporter that underwent tamoxifen-induced
Cre-ER (UBCCre-ERT2)-mediated CNS2 deletion were tagged by
YFP through the concomitant activation of R26Y recombination
reporter allele (Figure 1F). YFP expression was highly correlated
with CNS2 deletion, with only 4.7% ± 0.6% YFP-tagged cells
retaining the unrecombined allele as measured by quantitative
PCR (qPCR) (data not shown). To test the role of CNS2 in the
maintenance of Foxp3 expression in mature Treg cells in vivo,
we transferred highly purified YFP+GFP+ Treg cells (>99.8%
purity) from Foxp3CNS2fl-gfp UBCCre-ERT2 R26Y mice into T-cell-
deficient Tcrb/Tcrd/ recipients together with allelically
marked naive Ly5.1+ CD4+Foxp3 T cells and assessed Foxp3
expression 7 weeks after transfer. Because 50% GFP+YFP
Treg cells in tamoxifen-treated Foxp3CNS2fl-gfp UBCCre-ERT2
R26Y mice lost CNS2 and the R26Y underreported recombina-
tion at the Foxp3 locus (data not shown), we used YFPGFP+
Treg cells sorted from untreated Foxp3CNS2fl-gfp UBCCre-ERT2
R26Y mice or from tamoxifen-treated Foxp3CNS2fl-gfp R26Y
mice as negative controls. Consistent with our previous findings,
only a minor portion of control Treg cells lost Foxp3 expression
when analyzed 7 weeks after transfer (Figures 1G, S1E, and
S1F) (Rubtsov et al., 2010). In contrast, >55% of the progeny of
Treg cells subjected to acute CNS2 ablation lost Foxp3 expres-
sion. Because we transferred the majority of Treg cells with un-
recombined CNS2fl and the minority with ablated CNS2fl cells,
or control Foxp3gfp cells, the experimental and control groups
of recipient mice remained healthy. Thus, CNS2 maintains
Foxp3 expression in mature Treg cells.
The observation that only some mature Treg cells lost Foxp3
expression raised a question of whether the Treg cell population
is heterogeneous in its reliance onCNS2 for Foxp3maintenance,
with subsets of cells being dependent or independent ofCNS2. It
was possible, for example, that the loss of CNS2 affected only
CD25low Treg cells prone to Foxp3 loss (Komatsu et al., 2009;
Komatsu et al., 2013). Such a scenario implied that CNS2 acted
in a deterministic manner to maintain Foxp3 expression in a
CNS2-dependent Treg cell subset and that CNS2-deficient
Treg cells that retained Foxp3 expression after homeostatic
expansion were independent of CNS2 for Foxp3 maintenance.
Alternatively, it was possible that CNS2 was required for the
maintenance of Foxp3 expression in the entire population of
dividing Treg cells, but Foxp3 was lost in a stochastic manner.
To explore these alternatives, we isolated CNS2-sufficient
and -deficient YFP+GFP+ Treg cells 7 weeks after the first trans-
fer and transferred them again into T cell-deficient recipients.752 Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc.Five weeks after secondary transfer, we observed an essentially
identical pattern to that of the primary transfer, i.e.,60% loss of
Foxp3 expression in the absence of CNS2 (Figures 1F and 1G).
These results suggested that the loss of Foxp3 expression in
mature CNS2-deficient Treg cells was an apparently stochastic
event associated with their division.
CNS2 Sustains Heritable Foxp3 Expression in Mature
Treg Cells at Limiting Amounts of IL-2
We reasoned that the observed loss of Foxp3 by some Treg cells
was either due to the deprivation of a factor(s) that is required for
the maintenance of Foxp3 expression and is present in limiting
amounts or due to the exposure to a limiting factor(s) that re-
presses Foxp3 expression. IL-2 and STAT5 signaling plays an
important role in the regulation of Foxp3 expression (Fontenot
et al., 2005; Sakaguchi et al., 1995). Our recent cell fate mapping
studies showed that IL-2 deprivation caused by administration of
IL-2-neutralizing antibody results in a loss of Foxp3 expression
by only a minor subset (15%) of YFP-tagged Treg cells (Rubt-
sov et al., 2010), though this may be an underestimate because
IL-2/STAT5 signaling facilitates Treg cell viability. Thus, IL-2
could be a factor that ‘‘positively’’ acts via CNS2 and whose
deprivation leads to a pronounced loss of Foxp3 expression in
the absence of CNS2. Indeed, CNS2 contains multiple STAT5-
binding motifs and can be bound by STAT5 (Figure S1A) (Ogawa
et al., 2013; Yao et al., 2007).
Previous studies suggested that Treg cells expressing low
amounts of CD25, a subunit of high-affinity IL-2 receptor, are un-
stable, whereas CD25high Treg cells faithfully maintain Foxp3
expression. Thus, we sought to examine whether CNS2 is
required for the maintenance of Foxp3 expression only in
CD25low or in both CD25low and CD25high Treg cells in vivo that
are less or more efficient in IL-2 capture and signaling, respec-
tively, as assessed by STAT5 phosphorylation (Figure S2A).
Upon transfer into lymphopenic host, both CD25high and
CD25low CNS2-deficient Treg cells showed markedly reduced
ability to maintain Foxp3 expression upon cell division,
compared to their wild-type counterparts, with CD25low CNS2-
deficient Treg cells exhibiting the most pronounced Foxp3 loss
(Figures 2A and S2B). These results raised the possibility that
increased IL-2 signaling may rescue, at least in part, the loss of
Foxp3 expression.
We directly tested this idea by askingwhether provision of high
amounts of IL-2 can rescue, at least in part, the loss of Foxp3 in
CNS2-deficient Treg cells. Upon TCR engagement, CNS2-defi-
cient Treg cells that divided multiple times (R3, denoted as
‘‘dividing’’) largely maintained Foxp3 expression in the presence
of high amounts of IL-2, whereas at lower IL-2 levels, a marked
reduction in Foxp3 expression was observed on a per cell basis
as well as in the percentage of Foxp3+ cells (Figures 2B and 2C).
Expectedly, CNS2-deficient Treg cells that did not divide or
divided less than three times (‘‘nondividing’’) did not significantly
change Foxp3 expression in comparison to control Treg cells.
Reduced Foxp3 amounts on a per cell basis observed in
CNS2-deficient Treg cells in vivo and upon their division
in vitro were likely due to an incomplete Foxp3 protein turnover
in Treg cells with the silenced Foxp3 locus (Figures 1D, 2B,
and 2C). Importantly, similar analysis of mature Treg cells
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Figure 2. CNS2 Sustains Heritable Foxp3 Expression in Mature Treg Cells in the Presence of Limiting Amounts of IL-2
(A) The stability of Foxp3 expression is more sensitive to low levels of CD25 expression in CNS2-deficient Treg cells. Doubly sorted Ly5.2 CNS2-sufficient
(Foxp3gfp) and -deficient (Foxp3DCNS2-gfp) Treg cells were cotransferred with Ly5.1 naive CD4+Foxp3 T cells into T-cell-deficient Tcrb/ Tcrd/mice and were
recovered for analysis 5 weeks later. CNS2-sufficient (n = 5 per group), CNS2-deficient (n = 3 per group). Mean ± SEM.
(B and C) CNS2-deficient Treg cells are susceptible to low levels of IL-2. Treg cells were doubly sorted by FACS and were activated with plate-coated CD3 and
CD28 antibodies in the presence of titrated amounts of IL-2 for 4 days. Foxp3 expression in the dividing (R3 cell divisions) and nondividing (<3 cell divisions) cells
was monitored by flow cytometry. The data represent one of more than three independent experiments.
(D) ChIP-qPCR analysis of STAT5 binding to the Foxp3 locus in CNS2-sufficient and -deficient Treg cells. In-vitro-expanded FACS-purified Treg cells from
Foxp3gfp or Foxp3DCNS2-gfp male mice were stimulated with 500 U/ml IL-2 for 30 min. Relative enrichment was calculated by normalizing to background STAT5
binding to control region (GM5069). The data are shown as means ± SEMs of triplicates and represent one of three independent experiments.
(E) Expression of hypermorphic STAT5 (STAT5CA) rescues unstable Foxp3 expression in CNS2-deficient Treg cells in vivo. Treg cells from Ly5.2 UBCCre-ERT2
R26Y Foxp3CNS2fl-gfp and UBCCre-ERT2 R26Y/ R26-Stopfl-STAT5CA Foxp3CNS2fl-gfp were doubly sorted by FACS and cotransferred with naive Ly5.1 CD4+Foxp3
T cells into Tcrb/ Tcrd/mice. At 4weeks after tamoxifen gavage, YFP+ or YFP Ly5.2+ CD4+TCRb+ cells were isolated and analyzed for Foxp3 expression (six
mice per group). The data represent one of more than three independent experiments.
See also Figure S2.
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subjected to tamoxifen-induced deletion of a ‘‘floxed’’ CNS2
allele showed similar sensitivity of heritable Foxp3 expression
to low levels of IL-2 (Figure S2C). The observed effect was un-
likely due to a differential effect of IL-2 on the survival of
CNS2-sufficient versus -deficient Treg cells because provision
of IL-2 similarly increased the viability of both CNS2-sufficient
and -deficient Treg cells in vitro (Figure 2C). These results sug-
gested thatCNS2 confers the ability of dividing Treg cells to sus-
tain Foxp3 expression upon IL-2 deprivation.
These findings raised the possibility that the observed rescue
of CNS2 deficiency was due to increased STAT5 activation in
response to high amounts of IL-2. Previous studies showed
binding of STAT5 to CNS2 (Ogawa et al., 2013; Yao et al.,
2007). In agreement with these data, we found that, within the
Foxp3 locus, STAT5 binds predominantly to CNS2 and, to a
markedly lesser extent, to the Foxp3 promoter (Figure 2D). Inter-
estingly, in the absence of CNS2, binding of STAT5 was notice-
ably reduced in the Foxp3 promoter and in its 1.5 kb upstream
region, suggesting potential interaction between CNS2 and
these sites. This observation was consistent with the idea that
the partial rescue of the Foxp3 loss associated with CNS2
deficiency in the presence of high amounts of IL-2 was due to
heightened STAT5 activation. To address this possibility, we
took advantage of a conditional R26-STOPfl-STAT5CA/gfp trans-
gene encoding a constitutively active form of STAT5 (STAT5CA)
and aGFP reporter preceded by loxP site flanked STOP cassette
inserted into the Rosa26 locus (T.C. and A.Y.R., unpublished
data). Forced expression of STAT5CA transgene in mature Treg
cells upon deletion of a conditional CNS2 allele mediated by
tamoxifen-induced Cre rescued unstable Foxp3 expression
and restored Treg cell stability to a level observed in wild-type
Treg cells (>90% YFP+ cells were CNS2 deficient) (Figure 2E).
These results suggested that enhanced IL-2 signaling through
activation of STAT5 was able to compensate for the absence
ofCNS2 and thatCNS2 affords Treg cells the ability to effectively
sustain Treg identity at low levels of IL-2.
CNS2 Stabilizes Foxp3 Expression in the Presence of
Proinflammatory Cytokines
In contrast to the positive role of IL-2 signaling in stabilizing her-
itable Foxp3 expression, proinflammatory cytokines IL-6, IFNg,
IL-12, and IL-4 even in the presence of optimal amounts of
IL-2 severely compromised Foxp3 expression in dividing
CNS2-deficient Treg cells, whereas in CNS2-sufficient Treg
cells, only a fairly small loss of Foxp3 was observed (Figures
3A and S3A and data not shown). Because in vitro IL-4 exposure
caused particularly severe loss of Foxp3 expression in dividing
Treg cells, for further investigation of this phenomenon, we
focused on IL-4 as an example of proinflammatory cytokines.
Notably, the loss of Foxp3 expression induced by IL-4 in
CNS2-deficient Treg cells was also observed at the mRNA level
and was cell-cycle dependent (Figures S3A and S3B).
To explore whether STAT family members activated down-
stream of proinflammatory cytokine signaling bind to the Foxp3
locus and possibly compete with STAT5, we employed ChIP-
qPCR to examine STAT6- and STAT5-binding sites at the
Foxp3 locus in Treg cells stimulated with IL-2 and IL-4 or with
IL-2 alone. We found that, upon combined IL-2 and IL-4 stimula-754 Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc.tion, STAT6 and STAT5 bind to similar sites—namely, CNS2, the
Foxp3 promoter, and its 1.5 kb upstream region (Figure 3B).
Concomitant with STAT6 binding, STAT5 binding was markedly
reduced at the three main sites despite the presence of the same
amounts of IL-2 that was used in combination with IL-4 or alone
(Figure 3B). Of note, IL-2-dependent STAT5 phosphorylation
was comparable when Treg cells were stimulated with IL-2 in
the presence or absence of IL-4 (Figure S3C).
Because STAT5 and STAT6 bind to the same sites within the
Foxp3 locus and promote the maintenance and loss of Foxp3
expression, respectively, we asked what protein factors might
associate with STAT5 and STAT6 and might contribute to their
opposing activity. In light of the observed connection between
CpG methylation in the Foxp3 locus, cell division, and the loss
of Foxp3 expression (Figure 1C), we tested whether STAT5 or
STAT6 interact with DNA methyltransferases Dnmt1 and
Dnmt3a, responsible for maintenance and de novo DNA
methylation, respectively (Wu and Zhang, 2010). We found
that STAT6, but not STAT5, coprecipitates with Dnmt1 and,
to a lesser degree, with Dnmt3a (Figure 3C). In agreement
with a previous report (Zhang et al., 2005), we also observed
Dnmt1 association with STAT3 (data not shown) and STAT3
binding to the aforementioned STAT5-binding sites in the
Foxp3 locus (Figure S3D).
We previously reported that, after transient depletion of Treg
cells in Foxp3DTR mice, recovering Treg cells rapidly divide in
the presence of high amounts of Th2, Th1, and Th17 cytokines
(Arvey et al., 2014; Kim et al., 2007). Under these conditions,
we observed sharply increased CpG methylation at the
1.5 kb region and exon-1 in dividing activated Treg cells (Fig-
ure 3D). Furthermore, blockage of Dnmt activity with 5-aza-dC
resulted in considerable albeit partial rescue of impaired Foxp3
maintenance by dividing CNS2-deficient Treg cells in the pres-
ence of IL-4 in vitro (Figure 3E). Together, our data suggest
that STAT5 competes with STAT6 for the binding to the Foxp3 lo-
cus and prevents silencing of Foxp3 expression by opposing
STAT6-mediated recruitment of Dnmt1 to Foxp3 regulatory ele-
ments that are partially remethylated during Treg cell division.
CNS2-Dependent Heritable Foxp3 Expression and
Maintenance of Treg Cells in the Steady State
Next, we investigated the biological significance of heritable
Foxp3 expression in differentiated Treg cells. In agreement
with previous analysis of mice on a mixed genetic background,
Foxp3 DCNS2-gfp B6 mice displayed reduced Treg cell fre-
quency in the peripheral lymphoid organs and heightened
activation of effector T cells and proinflammatory cytokine
production in comparison to their Foxp3gfp littermates (Figures
6C and 6D). Because Treg cell frequency can be altered in
response to inflammation, we wanted to assess the impact
of CNS2 deficiency on Treg cell frequency in noninflammatory
settings. Therefore, we generated mixed bone marrow (BM)
chimeras by transferring allelically marked BM cells from
CNS2-deficient Ly5.2 Foxp3DCNS2-gfp and CNS2-sufficient
Ly5.1 Foxp3gfp male mice into irradiated T cell-deficient recipi-
ents (Figure 4A). Analyses of the ratios of CNS2-deficient
Ly5.2+ and -sufficient Ly5.1+ Treg cells showed that CNS2-defi-
cient and -sufficient Treg cells were equally represented in the
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Figure 3. IL-2-STAT5-CNS2 Axis Stabilizes Foxp3 Expression in the Presence of Proinflammatory Cytokines
(A) Dividing Foxp3DCNS2-gfp Treg cells lose Foxp3 expression upon exposure to proinflammatory cytokines. Doubly sorted Treg cells from UBCCre-ERT2 R26Y
Foxp3CNS2fl-gfp mice were activated in vitro with plate-coated CD3 and CD28 antibodies in the presence of IL-2 (500 U/ml) and proinflammatory cytokines.
Deletion of CNS2was induced upon treatment with 4-hydroxytamoxifen (4-OHT). Histograms show only the dividing cells (R3 divisions). The data represent one
of more than three independent experiments.
(B) ChIP-qPCR analysis of STAT5 and STAT6 binding to the Foxp3 locus in in-vitro-expanded FACS-purified Treg cells from Foxp3gfp mice and stimulated with
IL-2 and IL-4 for 30min. Relative enrichment was calculated by normalizing to the input of ChIP. The data are shown asmeans ±SEMs of triplicates and represent
one of three independent experiments.
(C) STAT6, but not STAT5, is associated with DNA methyltransferases. Dnmt1 and Dnmt3a coprecipitation with STAT5 and STAT6 was performed using nuclear
extracts from in-vitro-expanded FACS-purified Treg cells from Foxp3gfp mice as in (B). The data represent one of more than three independent experiments.
(D) Elevated CpG methylation in the Foxp3 locus in Treg cells expanding under inflammatory conditions in vivo. Activated Treg cells were FACS purified from
Foxp3DTR mice on day 10 after diphtheria toxin injection (see Extended Experimental Procedures). CpG methylation levels were averaged from >5,000 reads in
each site of the Foxp3 locus and were compared to control Treg cells and ex vivo isolated exTreg cells (see also Figure S1B). The data represent two independent
experiments. Mean ± SEM.
(E) Blockage of Dnmt activity with 5-aza-deoxycytidine (5-aza-dC) partially restores heritable Foxp3 expression in Treg cells exposed to IL-4. Doubly sorted Treg
cells from Ly5.1 Foxp3gfp and Ly5.2 Foxp3DCNS2-gfpmalemice were cocultured with CD3 andCD28 antibody-coated beads for 7 days in the presence of 500 U/ml
IL-2 with or without IL-4 or 0.1mM5-aza-dC. Relative increases in the percentages of Foxp3+ cells and Foxp3 expression (MFI) on a per cell basis were calculated.
The data represent one of more than three independent experiments. Mean ± SEM.
See also Figure S3.thymus (Ly5.2+/Ly5.1+ ratio 0.93) and that CNS2-deficient Treg
cells were only moderately underrepresented in the secondary
lymphoid organs (Ly5.2+/Ly5.1+ ratio 0.42-0.64) (Figure 4B). In
contrast, in nonlymphoid organs of these mice, we observed apronounced skewing toward CNS2-sufficient Treg cells
(Ly5.2+/Ly5.1+ ratio 0.15-0.36) and a marked decrease in the
level of Foxp3 protein expression on a per cell basis (Figure 4C).
Furthermore, CNS2-deficient Treg cells were underrepresentedCell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc. 755
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Figure 4. CNS2-Dependent Maintenance of Heritable Foxp3 Expression and Treg Cell Numbers in the Steady State
(A) Schematic of the generation of mixed bone marrow chimeras.
(B and C) Treg cell frequency and Foxp3 expression level in Ly5.1+ Foxp3gfp and Ly5.2+ Foxp3DCNS2-gfp cells in the thymus, spleen, lymph nodes (LN), mesenteric
lymph nodes (MLN), Peyer’s patch (PP), small intestine lamina propria (SI-LPL), liver, lungs, and visceral adipose tissue (VA) of the mixed BM chimeras. Per-
centages of Ly5.1+ and Ly5.2+ cells in the reconstituted Treg (CD4+GFP+Foxp3+) cells were normalized based on the reconstitution efficiency of total Ly5.1+ and
Ly5.2+ lymphocytes in the thymus. Mean ± SEM n = 9 per group; the data represent one of three independent experiments.
(D) Correlation of Ki67 expression with the difference in Foxp3 MFI between CNS2-sufficient and -deficient Treg cells (spleen).
(E) Reduced frequency of and lower Foxp3 expression level in Foxp3DCNS2-gfp Treg cells in activated Treg cell population (CD44highCD62Llow). Mean ± SEM.
(F) CD25 expression level was correlated with the frequency of CNS2-deficient Treg cells in the mixed population and was anticorrelated with the difference in
Foxp3 expression levels between CNS2-sufficient and -deficient Treg cells (spleen).
See also Figure S4.
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among dividing Ki67+ Treg cells, which was associated with
reduced Foxp3 expression level at the single-cell level (Figures
4D and S4A–S4C). Consistently, we observed reduced numbers
ofCNS2-deficient Treg cells and reduced levels of Foxp3 in acti-
vated (CD44highCD62Llow) dividing CNS2-deficient Treg cells
(Figures 4E, S4D, and S4E). In further support for the aforemen-
tioned notion that higher IL-2 signaling in Treg cells could
partially compensate for CNS2 deficiency, we noticed a marked
enrichment of cells expressing higher CD25 in CNS2-deficient
Treg cells and a correlation of the level of CD25 expression
with the frequency and the amount of Foxp3 expression in
CNS2-deficient Treg cells (Figure 4F and data not shown). These
observations suggested that, under noninflammatory condi-
tions, a key function of CNS2 is to maintain Foxp3 expression
in dividing Treg cells in nonlymphoid tissues.
CNS2 Prevents Differentiation of Treg Cells into
Effector Cells
Next, we asked whether CNS2 is required to prevent acquisition
of alternative cell fates, i.e., differentiation into effector cells, by
mature Treg cells under the condition of autoimmune inflamma-
tion. Previous studies demonstrated a prominent capacity of
Treg cells to limit inflammation in the brain and the spinal cord
and limb paralysis resulting from experimental autoimmune
encephalomyelitis (EAE). EAE serves as an animal model for mul-
tiple sclerosis and is induced upon immunization of mice with a
peptide derived from myelin oligodendrocyte glycoprotein
(MOG35-55) in complete Freund’s adjuvant (CFA) (Pachner,
2011; Stromnes and Goverman, 2006; Webster et al., 2009).
Furthermore, a recent study suggested that some Treg cells—
in particular, those specific for MOG35-55 peptide—lose
Foxp3 expression and become effector T cells in the course of
EAE (Bailey-Bucktrout et al., 2013). These observations raised
the question of whether CNS2 was dispensable under autoim-
mune inflammatory conditions because its function in the main-
tenance of Foxp3 expression was abolished. Alternatively, it was
possible that the requirement for CNS2was heightened and that
Foxp3 prevented deviation of Treg cells into proinflammatory
effector T cells under inflammatory conditions. To answer these
questions, we assessed Foxp3 and proinflammatory cytokine
expression by CNS2-deficient and -sufficient Treg cells present
in the same tissue inflammatory settings during the course of
EAE. To track the dynamics of cell populations in these experi-
ments, we adoptively transferred Treg cells double sorted from
Ly5.2 UBCCre-ERT2 Foxp3CNS2fl-gfp R26Y together with naive
Ly5.1+ CD4+Foxp3 T cells into lymphopenic recipients (Fig-
ure 5A). Mice were immunized with MOG peptide in CFA imme-
diately after acute depletion of CNS2 induced with tamoxifen in
30% of transferred Treg cells. Due to limited numbers of
effector T cells and 70% of Treg cells with the unrecombined
CNS2fl allele, we observed very mild disease (clinical score
1.5–2) in these recipients. We found that almost all (>95%)
CNS2-deficient Treg cells lost Foxp3 expression in the central
nervous system (brain and spinal cord); in contrast, around
one-third of CNS2-sufficient Treg cells retained Foxp3 expres-
sion (Figures 5B and 5C). Thus, CNS2-dependent stable inheri-
tance of Foxp3 expression plays a crucial role in maintaining
Treg cell numbers under local inflammatory conditions in vivo.Loss of Foxp3 expression by a cohort of Ly5.2+ CNS2-deficient
Treg cells was associated with acquisition of the production of
IL-2 and proinflammatory cytokines IFNg and IL-17 (Figure 5B
and C). Thus, under inflammatory conditions, CNS2 prevents
the loss of Foxp3 by dividing Treg cells, as well as their differen-
tiation into effector T cells. As a consequence of sharply reduced
Foxp3 levels, CNS2-deficient Treg cells displayed lower
amounts of CTLA4 and failed to effectively restrain autoimmune
disease upon cotransfer into T cell-deficient hosts with effector
CD4+ T cells isolated from Foxp3-deficient mice (Figures S5A
and S5B).
CNS2-Dependent Maintenance of Foxp3 Expression Is
Essential for Suppressing Chronic Inflammation
These results suggested that the failure to maintain the Treg cell
fate in the absence of CNS2 would result in heightened inflam-
mation and disease in a variety of settings due to a reduced sup-
pressor function of Treg cells and their increased conversion into
effector T cells (Figures 5 and S5). To test this idea, we evaluated
histopathology in aged 12- to 15-month-old Foxp3DCNS2-gfp
mice. We found that CNS2 deficiency resulted in severe inflam-
matory lesions in numerous nonlymphoid organs, including
lung, liver, stomach, and small and large intestine (Figure 6E
and data not shown). In addition, Foxp3DCNS2-gfp mice exhibited
decreased bodyweight, elevated circulating immunoglobulin (Ig)
levels, and activated effector T cells (Figures 6A–6C). Thus,
CNS2 deficiency results in spontaneous age-dependent inflam-
matory lesions in nonlymphoid organs.
As a consequence of inflammation, CNS2-deficient Treg cell
may lose more functional Treg cells due to cell division, proin-
flammatory cytokine exposure, and/or IL-2 deprivation (Figures
3A, 2B, and 2C). To directly test the impact of inflammation on
CNS2-deficient Treg stability in vivo without manipulation of
Treg cells in vitro, we immunized mixed bone marrow chimeras
of Ly5.1 Foxp3gfp and Ly5.2 Foxp3DCNS2-gfpmice withMOGpep-
tide and found that, in contrast to CNS2-sufficient Treg cells,
CNS2-deficient Treg frequency was remarkably lower in the cen-
tral nervous system, which was coupled with a dramatically
diminished Foxp3 protein level (Figure 7A). We also examined
the course of MOG peptide-induced EAE in Foxp3DCNS2-gfp
and Foxp3gfp mice. Although CNS2 deficiency did not impact
the onset of the disease or its severity during the initial progres-
sive phase, the disease in Foxp3DCNS2-gfp mice failed to remit
and exhibited a chronic, relentless course after reaching its
peak in contrast to the remitting-relapsing disease observed in
control Foxp3gfpmice (Figures 7B and S6A). The heightened clin-
ical manifestations, including limb paralysis and weight loss,
correlated with a diminished Treg cell frequency among lympho-
cytes present in the brain and the spinal cord (Figures S6B–S6D
and data not shown). Unlike other nonlymphoid tissues, Treg and
effector T cells were barely detectable in the brain and spinal
cord of unchallenged control and mutant animals (data not
shown). Thus, the more severe, relapse-free disease course is
unlikely due to a diminished pre-existing pool of Treg cells in
CNS2-deficient mice but is rather a consequence of a loss of
Foxp3 expression by CNS2-deficient Treg cells forced into the
cell cycle in the setting of a localized chronic autoimmune inflam-
mation (Figures 5 and 7A).Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc. 757
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Figure 5. CNS2-Dependent Inheritance of Foxp3 Expression Prevents Treg Cell Conversion to Effector Cells
(A) Schematic of the experimental design. Treg cells doubly sorted from Ly5.2 Foxp3CNS2fl-gfp UBCCre-ERT2 R26Y male mice were cotransferred with Ly5.1 naive
CD4+Foxp3 T cells into Tcrb/Tcrd/ recipients. Acute ablation of CNS2 was induced by tamoxifen gavage, and Ly5.2+CD4+TCRb+ T cells were analyzed
21 days after immunization with MOG35-55/CFA.
(B andC) YFP+ and YFP of Ly5.2+CD4+TCRb+ T cells were separated by FACS and stimulated with PMA and ionomycin, and cytokine production of the cells was
analyzed by flow cytometry. The data represent one of three independent experiments. CNS, combined infiltrated lymphocytes from the central nervous system
(brains and spinal cords).
See also Figure S5.In addition to spontaneous autoimmune lesions in nonlym-
phoid organs and autoantigen-driven focal autoimmunity, we
explored the role of CNS2-dependent maintenance of Treg
cell fate during sterile inflammation associated with obesity.
Because metabolic perturbation induced by a high-fat diet
(HFD) causes mild chronic inflammation (Feuerer et al., 2009),
we first investigated Treg cell frequency and effector T cell phe-
notypes in wild-type Foxp3gfp and Foxp3DCNS2-gfp mice that
were fed with 60 kcal % high-fat diet (>10 weeks). We found
that the frequency of CNS2-sufficient Treg cells was increased758 Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc.in spleen and liver but was decreased in visceral adipose tissue
in mice on a HFD. In contrast, the frequency of CNS2-deficient
Treg cells was not increased by HFD in comparison to regular
diet despite a marked increase in CD25+ cells in CNS2-
deficient mice (Figures 7C, 7D, and S7A–S7C). The failure to
increase Treg cell numbers was associated with a dramatic in-
crease in the numbers of activated effector CD44highCD62Llow
Foxp3CD4+ T cells in these mice (Figure 7C, right). These re-
sults suggest that chronic inflammation resulting from a meta-
bolic disorder requires continuous maintenance of Foxp3
A B C
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(legend on next page)
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expression when Treg cells divide in response to inflammatory
cues.
Finally, we assessed the role of CNS2 during chronic viral
infection. Foxp3DCNS2-gfpmice infected with chronic lymphocytic
choriomeningitis virus (LCMV) clone 13 showed a severe pro-
gression of the wasting disease during the chronic phase of
infection, which was less pronounced in control Foxp3gfp mice.
Interestingly, the weight loss of Foxp3DCNS2-gfp mice was com-
parable to control Foxp3gfpmice during the acute phase of infec-
tion (d7) but was severely increased during the chronic phase,
when Treg cells are massively expanding (Punkosdy et al.,
2011) (Figure 7E), suggesting that CNS2-dependent inheritable
maintenance of Treg cells is critical for limiting inflammation dur-
ing chronic viral infection.
Together, these data demonstrate the crucial role of CNS2-
dependent inheritance of Foxp3 expression and highlight a
mechanism bywhich a dedicated cis-element serves tomaintain
cellular identity during the vulnerable stage of cell division, a pre-
requisite for Treg cell function during immune homeostasis and
acute and chronic inflammation.
DISCUSSION
We found that Treg cell proliferation was a prerequisite for
silencing of the Foxp3 locus and that CNS2 opposed the shut-
down of Foxp3 expression. Previous studies showed that
CNS2 CpGs are methylated in immature Treg cells and are de-
methylated in mature Treg cells and that a demethylated state
of CNS2 was correlated with stable Foxp3 expression (Floess
et al., 2007; Polansky et al., 2008; Toker et al., 2013). Our anal-
ysis of stage-specific deletion ofCNS2 revealed that its function-
ality is conditional upon its demethylation in mature Treg cells
(data not shown). Thus, demethylated CNS2 opposed Foxp3
silencing in fully differentiated mature Treg cells in an apparently
stochastic manner, and the activity of CNS2 was continuously
required for the maintenance of heritable Foxp3 expression.
In search of factors that converge on CNS2 to maintain Foxp3
expression during cell division, we uncovered a key role of IL-2-
signaling-induced STAT5 activation, which was supported by
previous studies of IL-2 signaling in the differentiation and main-
tenance of Treg cells (Fontenot et al., 2005; Setoguchi et al.,
2005). Our results suggest that, at physiologic levels, IL-2
signaling stabilizes heritable Foxp3 expression in dividing
mature Treg cells to a large degree through CNS2. Consistent
with this notion and previous work, we found that STAT5 binds
to CNS2 and, to a lesser degree, to the Foxp3 promoter (Ogawa
et al., 2013; Yao et al., 2007). Importantly, in the absence of
CNS2, STAT5 binding to the Foxp3 promoter was markedly
reduced, suggesting that CNS2 may interact with the promoter
through a short-distance loop. Consistent with these results,Figure 6. CNS2-Dependent Inheritance of Treg Cell Identity Prevents S
(A) Diminished body weight of Foxp3DCNS2-gfpmice (12months old) in compariso
group. Mean ± SEM.
(B) Serum Ig levels in Foxp3DCNS2-gfp and littermate control mice (12 months ol
(C)FrequenciesofTregcellsandactivatedCD4+Foxp3Tcells (CD44highCD62Llow)
(D and E) Flow cytometric analyses of Foxp3 and CD25 expression, activation of,
12- to 15-month-old Foxp3DCNS2-gfp mice. Data represent one of two or more ind
760 Cell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc.heightened IL-2 signaling or induced expression of STAT5CA
restored stable Foxp3 expression in CNS2-deficient Treg cells.
On the other hand, exposure to proinflammatory cytokines,
including IL-4, IL-6, and IFNg, resulted in a markedly increased
loss of Foxp3 in dividing Treg cells in the absence of CNS2
despite the presence of optimal amounts of IL-2. IL-4-activated
STAT6 competes with STAT5 for the binding to similar sites in
the Foxp3 locus and counteracts STAT5 activity. Unlike
STAT5, STAT6 interacted with Dnmt1; CpG methylation at the
Foxp3 locus was increased during Treg cell division and, upon
loss of Foxp3 expression, was fully returned to the high methyl-
ation state of effector T cells. Of note, IL-6-activated STAT3 also
binds to the aforementioned sites within the Foxp3 locus and as-
sociates with Dnmt1 (data not shown) (Zhang et al., 2005).
Together, these observations suggest that, in the absence of
CNS2, STAT proteins activated downstream of proinflammatory
cytokine signaling may effectively compete with STAT5 for bind-
ing to the Foxp3 locus and may bring DNA methyltransferases
and thereby silence Foxp3 transcription. Our experiments indi-
cate that CNS2 likely increases STAT5 occupancy at the
Foxp3 promoter prior to inflammation and hence opposes proin-
flammatory cytokine-driven silencing of the Foxp3 locus. The
sum of the opposing effects of IL-2 and proinflammatory cyto-
kine signaling determines the inheritance of Foxp3 expression
and the fate of dividing Treg cells. Although in-depthmechanistic
understanding of this phenomenon would require careful quanti-
fication of active STAT proteins and their affinities for Foxp3-
binding sites in Treg cells, our results suggest that CNS2 skews
this balance by recruiting STAT5 to the Foxp3 promoter and
enabling Treg cells to withstand diminished IL-2 and heightened
inflammatory cytokine signaling. Thereby,CNS2 serves as a crit-
ical determinant of Treg cell lineage stability upon cell division in
inflammatory environments in which IL-2 amounts are limiting.
Under physiological conditions, CNS2 maintains the Treg cell
population and thereby prevents spontaneous age-dependent
inflammation in nonlymphoid organs. Furthermore, CNS2-
dependent maintenance of Foxp3 expression limits the chronic,
but not acute, phase of organ-specific autoimmune inflammation
and precludes the acquisition of effector functions by Treg cells
in response to inflammatory cues. Similarly, compromised inher-
itance of Foxp3 expression in Treg cells in the absence of CNS2
resulted in diminished health status in the course of chronic viral
infection as well as increased immune cell activation during ster-
ile metabolic inflammation.
It seems likely that the observed features of regulation of the
inheritance of Treg cell identity upon integration of extracellular
cues by a cis-regulatory element dedicated to cell fate mainte-
nance may be operational in other dividing cell types. Suscep-
tibility to a stochastic downregulation of the expression of a
lineage specification factor such as Foxp3 and the need for apontaneous Age-Dependent Autoimmunity
n to wild-type littermates. WT 36.45 ± 1.37 g,DCNS2 30.18 ± 0.88 g. n = 16 per
d) determined by ELISA. WT n = 6, Foxp3DCNS2-gfp n = 4. Mean ± SEM.
inFoxp3DCNS2-gfpandcontrolmice (3monthsold; n=5pergroup).Mean±SEM.
and cytokine production by CD4+ Foxp3 T cells and tissue histopathology in
ependent experiment. Mean ± SEM.
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Figure 7. CNS2-Dependent Maintenance of Foxp3 Expression Is Critical for Suppressing Chronic Inflammation
(A) Flow cytometric analysis of Foxp3 expression in CNS2-deficient Treg cells in the central nervous system after MOG immunization. Chimeric mice transferred
with Ly5.1 Foxp3gfp and Ly5.2 Foxp3DCNS2-gfpBM (see also Figure 4A) were immunized with MOG35-55 in CFA and were analyzed on day 14. Mean ± SEM, n = 9.
(B) Loss of CNS2 aggravates the chronic phase of EAE. Male Foxp3DCNS2-gfp and Foxp3gfp littermates were immunized with MOG35-55/CFA, and their body
weights and clinical disease scores were monitored. Mean + SEM. WT n = 8, Foxp3DCNS2-gfp n = 10. Data represent one of three independent experiments.
(C) Analysis of Treg and activated effector CD4+Foxp3 T cells in Foxp3DCNS2-gfp and littermate control male mice on a high-fat diet (HFD) and control diet (RD,
regular diet). Mice were fed with HFD or RD for 10 weeks before the analysis. Data represent one of more than three independent experiments. Mean ± SEM. WT
(RD) n = 5, WT (HFD) n = 8, Foxp3DCNS2-gfp (RD) n = 5, Foxp3DCNS2-gfp (HFD) n = 5.
(D) Flow cytometric analysis of CD25highKi67 Treg cells in Foxp3DCNS2-gfp and littermate control mice on a HFD diet.
(E) Body weight of Foxp3DCNS2-gfp and littermate control mice infected with LCMV clone 13 (p% 0.05). The data represent one of two independent experiments.
Mean ± SEM. WT n = 6, Foxp3DCNS2-gfp n = 5.
See also Figures S6 and S7.dedicated regulatory element to oppose such a loss might be
linked to the intrinsic inhibition of transcriptional activity, split-
ting and dilution of transcription factors, and histone modifica-
tions during cell division (Gottesfeld and Forbes, 1997; Mullen
et al., 2001; Probst et al., 2009). Thus, the mitosis-related tran-scriptional fluctuation could increase the probability of com-
plete transcriptional silencing of Foxp3 expression through
yet-to-be defined active or passive processes (Losick and Des-
plan, 2008). Considering the respective positive and negative
roles of IL-2 and proinflammatory cytokines in the heritableCell 158, 749–763, August 14, 2014 ª2014 Elsevier Inc. 761
expression of Foxp3, it seems likely that the promotion of cell
division by these factors may increase the vulnerability of
Treg cells to the loss of their identity due to the stochastic
silencing of Foxp3 by molecular mechanisms that remain to
be explored.
In conclusion, we found that CNS2, a cis-acting regulatory
element dedicated to heritable maintenance of the active state
of the Foxp3 locus, enables dividing Treg cells to maintain their
differentiated state upon deprivation of their essential growth
factor IL-2 and upon exposure to proinflammatory cues driving
alternative effector T cell differentiation.CNS2-dependent stabil-
ity of the Treg cell lineage is critical for preventing spontaneous,
age-dependent chronic inflammation in a variety of nonlymphoid
organs, for restraining metabolic inflammation associated with
diet-induced obesity, and for limiting organ-specific autoim-
munity as well as the wasting syndrome during chronic viral
infection.
EXPERIMENTAL PROCEDURES
See the Extended Experimental Procedures for further information
Animals
Foxp3DCNS2-gfp and Foxp3CNS2fl-gfp mice (Zheng et al., 2010) were back-
crossed onto C57BL/6 background for more than ten generations. Foxp3DTR
and Foxp3gfpko were described previously (Gavin et al., 2007; Kim et al.,
2007). R26-Stopfl-STAT5CA mice were generated by inserting a coding
sequence of STAT5CA and a GFP reporter into the Rosa26 locus (Sasaki
et al., 2006) (T.C. and A.Y.R., unpublished results). All animals weremaintained
in the MSKCC animal facility under SPF conditions, and the experiments were
performed according to the institutional guidelines (IACUC 08-10-023).
Generation of BoneMarrowChimeras and Adoptive T Cell Transfers
For the generation of bone marrow (BM) chimeras, recipient mice were irradi-
ated (9.5 Gy) 24 hr prior to bone marrow stem cell transfer. BM cells were
depleted of T cells with Dynabeads FlowComp Mouse Pan T kit (Life Technol-
ogies) and were injected i.v. into irradiated recipients. After BM transfer, recip-
ient mice received neomycin with drinking water (2 mg/ml) for 3 weeks and
were analyzed 8–12 weeks later.
For adoptive cell transfers, Treg cells were purified from Foxp3gfp,
Foxp3DCNS2-gfp, or Foxp3CNS2fl-gfp males by double-FACS sorting based on
GFP expression after enrichment of CD4 T cells with Dynal magnetic beads
(Life Technologies) and were cotransferred with congenically labeled (Ly5.1)
naive CD4+Foxp3 T cells at a 1:5 ratio (total 2.5 3 106 cells per recipient)
into T-cell-deficient Tcrb/Tcrd/ recipients. Transferred cell subsets were
analyzed by flow cytometry 4 weeks later.
Statistical Analysis
For statistical analysis, unpaired two-tailed Student’s t test was performed us-
ing Prism (GraphPad) or Excel (Microsoft). Regression analysis and plotting
were performed with Excel. *p % 0.05, **p % 0.01, ***p % 0.001, and **** p
% 0.0001.
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